Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019; https://doi.org/10.1038/s41575-019-0189-8.
International Agency for Research on Cancer. Globocan 2018: Cancer Fact Sheets — Colorectal Cancer. IARC. 2018. http://gco.iarc.fr/today/data/factsheets/cancers/10_8_9-Colorectum-fact-sheet.pdf.
Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol. 2012;3:153–73.
PubMed
PubMed Central
Google Scholar
Inamura K. Colorectal cancers: an update on their molecular pathology. Cancers (Basel). 2018;10:26.
Google Scholar
Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138:2044–58.
CAS
PubMed
Google Scholar
Graff RE, et al. Familial risk and heritability of colorectal cancer in the nordic twin study of cancer. Clin Gastroenterol Hepatol. 2017;15:1256–64.
PubMed
PubMed Central
Google Scholar
Virostko J, Capasso A, Yankeelov T, Goodgame B. Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer data base, 2004-2015. 2019. https://doi.org/10.1002/cncr.32347.
Folkesson J, Martling A, Kodeda K. Current considerations in colorectal cancer surgery. Colorectal Cancer. 2015;4:167–74.
Google Scholar
Gustavsson B, Carlsson G, Machover D, Petrelli N, Roth A, Schmoll HJ, Tveit KM, Gibson F. A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer. 2015;14:1–10.
CAS
PubMed
Google Scholar
Dagoglu N, Mahadevan A, Nedea E, Poylin V, Nagle D. Stereotactic body radiotherapy (SBRT) reirradiation for pelvic recurrence from colorectal cancer. J Surg Oncol. 2015;111:478–82.
PubMed
Google Scholar
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet. 2010;375:1030–47.
PubMed
Google Scholar
Van der Jeught K, Xu H-C, Li Y-J, et al. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol. 2018;24(34):3834–48.
PubMed
PubMed Central
Google Scholar
Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res. 2000;6:1322–7.
CAS
PubMed
Google Scholar
Yaffee P, Osipov A, Tan C, Tuli R, Hendifar A. Review of systemic therapies for locally advanced and metastatic rectal cancer. J Gastrointest Oncol. 2015;6:185–200.
PubMed
PubMed Central
Google Scholar
Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–17.
PubMed
Google Scholar
Milczarek M, Rosinska S, Psurski M, Maciejewska M, Kutner A, Wietrzyk J. Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin. Anticancer Res. 2013;33(2):433–44.
CAS
PubMed
Google Scholar
Imajo M, Tsuchiya Y, Nishida E. Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life. 2006;58:312–7.
CAS
PubMed
Google Scholar
Marshall MS. Ras target proteins in eukaryotic cells. FASEB J. 1995;9:1311–8.
CAS
PubMed
Google Scholar
Qi M, Elion EA. MAP kinase pathways. J Cell Sci. 2005;118:3569–72.
CAS
PubMed
Google Scholar
Azam M, Al-Resayes SI, Soliman SM, Trzesowska-Kruszynska A, Kruszynski R, Khan Z. A (salicylaldiminato)PT(II) complex with dimethylpropylene linkage:synthesis, structural characterization and antineoplastic activity. J Photochem Photobiol B Biol. 2017;176:150–6.
CAS
Google Scholar
Gamage CDB, Park S-Y, Yang Y, et al. Deoxypodophyllotoxin exerts anti-cancer effect on colorectal cancer cells through induction of apoptosis and suppression of tumorigenesis. Int J Mol Sci. 2019;20:2612. https://doi.org/10.3390/ijms20112612.
Article
CAS
PubMed Central
Google Scholar
Ahmad R, Vaali-Mohammed M-A, Elwatidy M, et al. Induction of ROS-mediated cell death and activation of the JNK pathway by a sulfonamide derivate. Int J Mol Medicine. 2019;44(4):1552–6.
CAS
Google Scholar
Al-Khayal K, Alafeefy A, Vaali-Mohammed M-A, et al. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration. BMC Cancer. 2017;17:4.
PubMed
PubMed Central
Google Scholar
Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today. 1994;15:7–10.
CAS
PubMed
Google Scholar
Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84:131–41.
CAS
PubMed
Google Scholar
Anderson ME. Glutathione: an overview of bio-synthesis and modulation. Chem Biol Interact. 1998;111–2:1–14.
Google Scholar
Hammond CL, Lee TK, Ballatori N. Novel roles for glutathione in gene expression, cell death, and mem-brane transport of organic solutes. J Hepatol. 2001;34:946–54.
CAS
PubMed
Google Scholar
Chen X, Carystinos GD, Batist G. Potential for selective modulation of glutathione in cancer chemotherapy. Chem Biol Interact. 1998;111–2:263–75.
Google Scholar
Waterhouse NJ, Goldstein JC, Ahsen OV, et al. Cytochrome c maintains mitochondrial membrane potential and ATP generation after outer mitochondrial membrane permeabilization during apoptosis process. J Cell Biol. 2001;153:319–28.
CAS
PubMed
PubMed Central
Google Scholar
Shamas-Din A, Kale J, Leber B, Andrews DW. Mechanism of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol. 2013;5:a008714.
Casimiro MC, Crosariol M, Loro E, Li Z, Pestell RG. Cyclins and cell cycle control in cancer and disease. Genes Cancer. 2012;3:649–57.
CAS
PubMed
PubMed Central
Google Scholar
Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis. 2002;7:321–8.
CAS
PubMed
Google Scholar
Bratton SB, Salvesen GS. Regulation of the Apaf1-caspase-9 apoPTosome. J cell Sci. 2010;123:3209–14.
CAS
PubMed
PubMed Central
Google Scholar
Raj, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 2011;475:231–4.
CAS
PubMed
PubMed Central
Google Scholar
Zikaki K, Aggeli IK, Gaitanaki C, Beis I. Curcumin induces theapoPTotic intrinsic pathway via upregulation od reactive oxygen species and JNKs in H9c2 cardiac myoblasts. Apoptosis. 2014;19:958–74.
CAS
PubMed
Google Scholar
Chen L, Jiang K, Chen H, et al. Deguelin induces apoptosis in colorectal cancer cancer cells by activating the p38 MAPK pathway. Cancer Manag Res. 2019;11:95–105.
CAS
PubMed
Google Scholar
Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of athree-kinase module from yeast to human. Physiol Rev. 1999;79:143–80.
CAS
PubMed
Google Scholar
Chang L, Karin M. Mammalian MAP kinase signal-ling cascades. Nature. 2001;410:37–40.
CAS
PubMed
Google Scholar
Yuan J, Rozengurt. PKD, PKD2 and p38 MAPK mediate Hsp27 Serine-82 phosphorylation induced ny neurotensin in Pancreatic Cancer PANC-1 cells. J Cell Biochem. 2008;103:648–62.
CAS
PubMed
Google Scholar
Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumor agents. Nature. 1969;222:385–6.
CAS
PubMed
Google Scholar
Weiss RB, Christian MC. New cispalatin analogues in development. A review. Drugs. 1993;46:360–77.
CAS
PubMed
Google Scholar
Gasser G, Ott I, Metzler-Nolte N. Organometallic anticancer compounds. J Med Chem. 2011;54:3–25.
CAS
PubMed
Google Scholar
Stoehlmacher J. Prediction of efficacy and side effects of chemotherapy in colorectal cancer. Recent Results Cancer Res. 2007;176:81–8.
CAS
PubMed
Google Scholar
Sava G, Bergamo A, Duson PJ. Metal-based antitumor drugs in the post-genomic era: what comes next? Dalton Trans. 2011;40:9069–75.
CAS
PubMed
Google Scholar
Lazarevic T, Rilak A, Bugarcic ZD. Platinum, palladium, gold and ruthenium complexes as antitumor agents: current clinical uses, cytotoxicity studies and future perspectives. Euro J Med Chem. 2017;142:8–31.
CAS
Google Scholar
Silva TM, Andersson S, Sukumaran SK, et al. Norspermidine and novel Pd(II) and Pt(II) polynuclear complexes of norspermidine as potential antineoplastic agents against breast cancer. PLoS One. 2013;8:e55651.
CAS
PubMed
PubMed Central
Google Scholar
Bostancioglu RB, Isik K, Genc H, et al. Studies on the cytotoxic, apoptotic and antitumoral effect of au (III) and Pt (II) complexes of 1, 10-phenanthroline on V79379A and A549 cell lines. J Enz Inhib Med Chem. 2011:1–9.
Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87. https://doi.org/10.1186/1756-9966-30-8748.
Tolan D, Gandin V, Morrison L, et al. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position. Sci Reports. 2016;6:29367.
Google Scholar
Mitra K, Gautam S, Kondaiah P, Chakravarty AR. Platinum (II) complexes of cucumin showing photocytotoxicity in visible light. Eur J Inorg Chem 2017;1753-63. https://doi.org/10.1002/ejic.201601078.
Kirtonia A, Sethi G, Garg M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci. 2020; https://doi.org/10.1007/s00018-020-03536-5.
Wilmanski T, Zhou X, Zheng W, et al. Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression. Cancer Lett. 2017;411:171–81.
CAS
PubMed
PubMed Central
Google Scholar
Wilmanski T, Zhou X, Zheng W et al. Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression. Cancer Letters 2017, 411, 171-181.
Rahman F-U, Ali A, Duong H-Q, et al. ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway. Eur J Med Chem. 2019;164:546–61.
CAS
PubMed
Google Scholar
Kowalski S, Wyrzykowski D, Hac S, et al. New oxidovanadium(IV) coordination complex containg 2-methylnitrilotriacetate ligands induces cell cycle arrest and autophagy in human pancreatic ductal adenocarcinoma cell lines. In J Mol Sci. 2019;20:261.
Google Scholar
Silva SLR, Bliza IRS, Dias RB, et al. Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling. Sci Rep. 2019;9:11094.
PubMed
PubMed Central
Google Scholar
Taniguchi K, Karin M. NFkB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18:309–24.
CAS
PubMed
Google Scholar
Sethi G, Ahn KS, Sung B, Aggarwal BB. Pinistol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion and angiogenesis. Mol Cancer Ther. 2008;7:1604–14.
CAS
PubMed
Google Scholar
Wong ALA, Hirpara JL, Pervaiz S, Eu J-Q, Sethi G, Goh B-C. Do STAT3 inhibitors have potential in the future for cancer therapy. Expert Opin Investig Drugs. 2017;26:883–7.
CAS
PubMed
Google Scholar
Zhu Y, Zhang M, Luo L, et al. NFkB hijacking theranostic Pt(II) complex in cancer therapy. Theranostics. 2019;9:2158–66.
CAS
PubMed
PubMed Central
Google Scholar
Brabec V, Kasparkova J, Kostrhunova H, et al. Inhibition of nuclear factor kappaN proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes. Sci Rep. 2016;6:28474 https://doi.org/10.1038/srep28474.
CAS
PubMed
PubMed Central
Google Scholar